Valsartan Recall Expanded, FDA Investigating Products From Outside China
Other ARB manufacturers subject to FDA investigation
This story was originally published Aug. 10, 2018. As part of MedPage Today's year-end review of 2018's top stories, we are republishing it along with an update on what has happened since with contamination issues affecting valsartan and other angiotensin receptor blockers.